#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer


Aberrant DNA methylation is an important cancer hallmark, yet the dynamics of DNA methylation changes in human carcinogenesis remain largely unexplored. Moreover, the role of DNA methylation for prediction of clinical outcome is still uncertain and confined to specific cancers. Here we perform the most comprehensive study of DNA methylation changes throughout human carcinogenesis, analysing 27,578 CpGs in each of 1,475 samples, ranging from normal cells in advance of non-invasive neoplastic transformation to non-invasive and invasive cancers and metastatic tissue. We demonstrate that hypermethylation at stem cell PolyComb Group Target genes (PCGTs) occurs in cytologically normal cells three years in advance of the first morphological neoplastic changes, while hypomethylation occurs preferentially at CpGs which are heavily Methylated in Embryonic Stem Cells (MESCs) and increases significantly with cancer invasion in both the epithelial and stromal tumour compartments. In contrast to PCGT hypermethylation, MESC hypomethylation progresses significantly from primary to metastatic cancer and defines a poor prognostic signature in four different gynaecological cancers. Finally, we associate expression of TET enzymes, which are involved in active DNA demethylation, to MESC hypomethylation in cancer. These findings have major implications for cancer and embryonic stem cell biology and establish the importance of systemic DNA hypomethylation for predicting prognosis in a wide range of different cancers.


Vyšlo v časopise: The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002517
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002517

Souhrn

Aberrant DNA methylation is an important cancer hallmark, yet the dynamics of DNA methylation changes in human carcinogenesis remain largely unexplored. Moreover, the role of DNA methylation for prediction of clinical outcome is still uncertain and confined to specific cancers. Here we perform the most comprehensive study of DNA methylation changes throughout human carcinogenesis, analysing 27,578 CpGs in each of 1,475 samples, ranging from normal cells in advance of non-invasive neoplastic transformation to non-invasive and invasive cancers and metastatic tissue. We demonstrate that hypermethylation at stem cell PolyComb Group Target genes (PCGTs) occurs in cytologically normal cells three years in advance of the first morphological neoplastic changes, while hypomethylation occurs preferentially at CpGs which are heavily Methylated in Embryonic Stem Cells (MESCs) and increases significantly with cancer invasion in both the epithelial and stromal tumour compartments. In contrast to PCGT hypermethylation, MESC hypomethylation progresses significantly from primary to metastatic cancer and defines a poor prognostic signature in four different gynaecological cancers. Finally, we associate expression of TET enzymes, which are involved in active DNA demethylation, to MESC hypomethylation in cancer. These findings have major implications for cancer and embryonic stem cell biology and establish the importance of systemic DNA hypomethylation for predicting prognosis in a wide range of different cancers.


Zdroje

1. JonesPABaylinSB 2007 The epigenomics of cancer. Cell 128 683 692

2. BaylinSBJonesPA 2011 A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11 726 734

3. CarterSLEklundACKohaneISHarrisLNSzallasiZ 2006 A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38 1043 1048

4. TingDTLipsonDPaulSBranniganBWAkhavanfardS 2011 Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331 593 596

5. WidschwendterMFieglHEgleDMueller-HolznerESpizzoG 2007 Epigenetic stem cell signature in cancer. Nat Genet 39 157 158

6. OhmJEMcGarveyKMYuXChengLSchuebelKE 2007 A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heriTable Silencing. Nat Genet 39 237 242

7. LeeTIJennerRGBoyerLAGuentherMGLevineSS 2006 Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 301 313

8. O'HaganHMWangWSenSDestefano ShieldsCLeeSS 2011 Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands. Cancer Cell 20 606 619

9. MaegawaSHinkalGKimHSShenLZhangL 2010 Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 20 332 340

10. RakyanVKDownTAMaslauSAndrewTYangTP 2010 Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20 434 439

11. TeschendorffAEMenonUGentry-MaharajARamusSJWeisenbergerDJ 2010 Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20 440 446

12. Lister RPMDowenRHHawkinsRDHonGTonti-FilippiniJNeryJRLeeLYeZNgoQM 2009 Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 315 322

13. PastorWAPapeUJHuangYHendersonHRListerR 2011 Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473 394 397

14. WilliamsKChristensenJPedersenMTJohansenJVCloosPA 2011 TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473 343 348

15. FiczGBrancoMRSeisenbergerSSantosFKruegerF 2011 Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473 398 402

16. GuTPGuoFYangHWuHPXuGF 2011 The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature

17. WuHD'AlessioACItoSXiaKWangZ 2011 Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473 389 393

18. BibikovaMFanJB 2010 Genome-wide DNA methylation profiling. Wiley Interdiscip Rev Syst Biol Med 2 210 223

19. BermanBPWeisenbergerDJAmanJFHinoueTRamjanZ 2011 Regions of focal DNA hypermethylation and long range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nature Genetics

20. KitchenerHCAlmonteMGilhamCDowieRStoykovaB 2009 ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess 13 1 150, iii–iv

21. KitchenerHCAlmonteMThomsonCWheelerPSargentA 2009 HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10 672 682

22. ApostolidouSHadwinRBurnellMJonesABaffD 2009 DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 125 2995 3002

23. NavabRStrumpfDBandarchiBZhuCQPintilieM 2011 Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 108 7160 7165

24. Ben-PorathIThomsonMWCareyVJGeRBellGW 2008 An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40 499 507

25. EppertKTakenakaKLechmanERWaldronLNilssonB 2011 Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17 1086 1093

26. SubramanianATamayoPMoothaVKMukherjeeSEbertBL 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 15545 15550

27. HeYFLiBZLiZLiuPWangY 2011 Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333 1303 1307

28. HembergerMDeanWReikW 2009 Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat Rev Mol Cell Biol 10 526 537

29. CokusSJFengSZhangXChenZMerrimanB 2008 Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452 215 219

30. WidschwendterMBergerJHermannMMullerHMAmbergerA 2000 Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 92 826 832

31. JohnsonWELiCRabinovicA 2007 Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8 118 127

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#